Demonstration of physicochemical and functional similarity between the proposed biosimilar adalimumab MSB11022 and Humira (R)

Magnenat, L; Palmese, A; Fremaux, C; D'Amici, F; Terlizzese, M; Rossi, M; Chevalet, L

Magnenat, L (reprint author), Merck Biosimilars, Non Clin Pharmacol, Aubonne, Switzerland.

MABS, 2017; 9 (1): 127

Abstract

Biosimilars are biological products that are highly similar to existing products approved by health authorities. Demonstration of similarity starts wi......

Full Text Link